Focus: Theravance Biopharma is a small-molecule focused pharmaceutical company headquartered in South San Francisco, generating 100% of revenue from its single marketed product VIBATIV (telavancin). The company operates as a specialty pharma with a diversified pipeline spanning respiratory, immunology, infectious diseases, gastroenterology, and nephrology.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Theravance Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Theravance Biopharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Sole marketed product generating 100% of company revenue; peak lifecycle status indicates mature commercialization with limited near-term growth but foundational cash generation.
Help build intelligence for Theravance Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles